These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 2839497
1. Receptor-mediated endocytosis of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Owensby DA, Sobel BE, Schwartz AL. J Biol Chem; 1988 Aug 05; 263(22):10587-94. PubMed ID: 2839497 [Abstract] [Full Text] [Related]
2. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1. Morton PA, Owensby DA, Sobel BE, Schwartz AL. J Biol Chem; 1989 May 05; 264(13):7228-35. PubMed ID: 2540181 [Abstract] [Full Text] [Related]
3. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells. Grimsley PG, Normyle JF, Brandt RA, Joulianos G, Chesterman CN, Hogg PJ, Owensby DA. Thromb Res; 1995 Aug 15; 79(4):353-61. PubMed ID: 7482438 [Abstract] [Full Text] [Related]
4. Endocytosis and lysosomal delivery of tissue plasminogen activator-inhibitor 1 complexes in Hep G2 cells. Underhill DM, Owensby DA, Morton PA, Schwartz AL. Blood; 1992 Dec 01; 80(11):2746-54. PubMed ID: 1333299 [Abstract] [Full Text] [Related]
5. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Otter M, Van Berkel TJ, Rijken DC. Thromb Haemost; 1989 Sep 29; 62(2):667-72. PubMed ID: 2510347 [Abstract] [Full Text] [Related]
6. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. Bu G, Maksymovitch EA, Schwartz AL. J Biol Chem; 1993 Jun 15; 268(17):13002-9. PubMed ID: 8389767 [Abstract] [Full Text] [Related]
7. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor. Bu G, Morton PA, Schwartz AL. J Biol Chem; 1992 Aug 05; 267(22):15595-602. PubMed ID: 1322401 [Abstract] [Full Text] [Related]
8. The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes. Wing LR, Bennett B, Booth NA. FEBS Lett; 1991 Jan 14; 278(1):95-7. PubMed ID: 1847116 [Abstract] [Full Text] [Related]
9. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells. Morton PA, Owensby DA, Wun TC, Billadello JJ, Schwartz AL. J Biol Chem; 1990 Aug 25; 265(24):14093-9. PubMed ID: 2167306 [Abstract] [Full Text] [Related]
10. Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells. Nguyen G, Self SJ, Camani C, Kruithof EK. J Biol Chem; 1992 Mar 25; 267(9):6249-56. PubMed ID: 1313432 [Abstract] [Full Text] [Related]
11. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2. Owensby DA, Morton PA, Schwartz AL. J Biol Chem; 1989 Oct 25; 264(30):18180-7. PubMed ID: 2553701 [Abstract] [Full Text] [Related]
12. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling. Sathre KA, Tsang ML, Weatherbee JA, Steer CJ. Hepatology; 1991 Aug 25; 14(2):287-95. PubMed ID: 1650327 [Abstract] [Full Text] [Related]
13. Kinetics of low-density lipoprotein receptor activity in Hep-G2 cells: derivation and validation of a Briggs-Haldane-based kinetic model for evaluating receptor-mediated endocytotic processes in which receptors recycle. Harwood HJ, Pellarin LD. Biochem J; 1997 May 01; 323 ( Pt 3)(Pt 3):649-59. PubMed ID: 9169597 [Abstract] [Full Text] [Related]
14. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Sitter T, Toet K, Quax P, Kooistra T. Kidney Int; 1999 Jan 01; 55(1):120-9. PubMed ID: 9893120 [Abstract] [Full Text] [Related]
15. alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells. Hajjar KA, Reynolds CM. J Clin Invest; 1994 Feb 01; 93(2):703-10. PubMed ID: 8113404 [Abstract] [Full Text] [Related]
16. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells. Iadonato SP, Bu G, Maksymovitch EA, Schwartz AL. Biochem J; 1993 Dec 15; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086 [Abstract] [Full Text] [Related]
17. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line. Simmons CF, Schwartz AL. Mol Pharmacol; 1984 Nov 15; 26(3):509-19. PubMed ID: 6092900 [Abstract] [Full Text] [Related]
18. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein. Camani C, Gavin O, Bertossa C, Samatani E, Kruithof EK. Eur J Biochem; 1998 Feb 01; 251(3):804-11. PubMed ID: 9490055 [Abstract] [Full Text] [Related]
19. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Rijken DC, Otter M, Kuiper J, van Berkel TJ. Thromb Res Suppl; 1990 Feb 01; 10():63-71. PubMed ID: 2107599 [Abstract] [Full Text] [Related]
20. Modulation of surface-associated urokinase: binding, interiorization, delivery to lysosomes, and degradation in human keratinocytes. Del Rosso M, Fibbi G, Pucci M, Dini G, Grappone C, Nolli ML. Exp Cell Res; 1991 Apr 01; 193(2):346-55. PubMed ID: 1848516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]